Clinical Trial Update: Re-usable Respimat® Soft MistTM Inhaler Study

View source ↗

Summary

Clinical trial update for a re-usable Respimat Soft Mist inhaler in chronic obstructive pulmonary disease; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Respimat Soft Mist Inhaler

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2021-03-03